SBI Securities’s Centessa Pharmaceuticals CNTA Stock Holding History

SBI Securities’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-30	Closed	-$1.19K	–	4095
2026 Q1	$1.19K	Buy	30 +5	+20%	+$128	﹤0.01%	2594
2025 Q4	$625	Buy	25 +4	+19%	+$101	﹤0.01%	2795
2025 Q3	$509	Buy	+21	New	+$373	﹤0.01%	2952

SBI Securities's CNTA Position: Q2 2026 in Review

SBI Securities sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 30 shares — an estimated $1.19K sold.

SBI Securities first reported a position in CNTA in Q3 2025 and held it in 3 quarters. The position peaked at $1.19K in Q1 2026. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

SBI Securities reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
SBI Securities sold 30 Centessa Pharmaceuticals shares in Q2 2026, an estimated $1.19K.
SBI Securities first reported a position in Centessa Pharmaceuticals in Q3 2025 and held it in 3 quarters.
SBI Securities's Centessa Pharmaceuticals position peaked at $1.19K in Q1 2026.
0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.